Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel iodine-catalyzed route for Brexpiprazole intermediate using low-cost thiophene. Reduces palladium dependency and enhances supply chain stability.
Patent CN116874482B details cobalt-catalyzed synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel patent CN117964557A offers high-yield Resmetirom intermediate synthesis. Reduces impurities and avoids column chromatography for cost-effective manufacturing.
Patent CN108676048B reveals a novel adenosine-based route for cordycepin. Achieve high purity and cost reduction in nucleoside manufacturing with scalable catalytic transfer hydrogenation.
Patent CN104725193A details asymmetric catalysis for high-purity marine natural product synthesis, offering improved yield and supply chain reliability for pharmaceutical intermediates.
Patent CN112110862B reveals mild synthesis for Linezolid impurity standards. Enhances supply chain reliability and reduces manufacturing complexity significantly.
Advanced synthesis of Diclofenac Sodium via mild acylation and rearrangement. Reduces steps and improves purity for reliable API intermediate supply chains.
Patent CN102153609B details a silica gel catalyst method for 6-methylene monoester, offering 88.2% yield and stable content for pharmaceutical supply chains.
Patent CN101052619A details an improved industrial process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate, offering significant supply chain and cost advantages.
Advanced synthesis of MMP inhibitors via novel Friedel-Crafts and Sonogashira coupling. Cost-effective manufacturing for high-purity pharmaceutical intermediates.
Novel acid-catalyzed esterification method for flurbiprofen derivatives offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Novel asymmetric synthesis of (3R)-3-tertbutyldimethylsiloxy-6-dialkoxyphosphono-5-oxo-tertbutyl hexanate via chiral resolution-free route for high-purity statin production.
Novel resolution method ensures high purity acetate salt stability for scalable API manufacturing and significant cost reduction in production.
Patent CN105440076A details a mild esterification process for tenofovir disoproxil fumarate offering high purity and significant cost reduction in API manufacturing.
Patent CN106366089B reveals a heavy-metal-free route for high-purity isoindoline derivatives ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105669606B details a novel CDI-mediated route for high-optical-purity intermediates. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing without Grignard reagents.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Patent CN108840838B reveals stable nickel catalyst for 1,1-diarylethane synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1930112A reveals a Lewis acid-catalyzed route for high-purity quinolone intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.